Presentation 3
BioDesigners, company builder's role in Korea


이동호 Dongho Lee

Founding CEO of BioDesigners, Co. Ltd

Dr. Dongho Lee is co-founder of BioDesigners and also BOD member of Hanmi Pharmaceuticals, a leading company in Korean pharma industry. He is retired professor of Clinical Pharmacology /Anesthesiology and Pain Management at Asan Medical Center, College of Medicine, Ulsan University.

He worked as a founding CEO of Korea Drug Development Fund (KDDF) from year 2011 to 2014, a government-initiated drug development project with a collaborative effort of healthcare-related Korean ministries, providing a total budget of one billion dollars. He brings more than 30 years of clinical and pharmaceutical business experience and expertise to KDDF, building the infrastructure and global network and nurturing specialist groups to advance the drug development activities in Korea.

Prior to KDDF, Dr. Lee served as Executive Director of Clinical Trial Center at Asan Medical Center, one of the top clinical trial centers in Korea, for 5 years. During this period, he also acted as Vice President at Korea National Enterprise for Clinical Trials (KoNECT), a government-supported organization to build and provide advanced clinical trial infrastructure and core technologies, where he played a leadership role in selecting and managing new regional clinical trial sites.

Beginning his career in pharmaceutical business in 2001 at GlaxoSmithKline (GSK) in Korea as Medical Director, he set up and led a new team to manage global clinical trials. After three years and half at GSK, he joined Samyang Corporation, a local pharmaceutical company in Korea, where he served as Head of Pharmaceutical Business Unit and Research Center.

Dr. Lee is a board-certified anesthesiologist with almost 20 years of clinical and medical experience as a professor at Hanyang University School of Medicine and Asan Medical Center. He obtained his MD degree at Seoul National University in 1979 and received MBA from Korea University in 2006.